These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15209536)

  • 21. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R; Cohen PR
    Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VNTR I/I genotype of insulin gene is associated with the increase of follicle number independent from polycystic ovary syndrome.
    Haller K; Laisk T; Peters M; Talving E; Karits P; Karro H; Uibo R; Salumets A
    Acta Obstet Gynecol Scand; 2007; 86(6):726-32. PubMed ID: 17520407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Hum Reprod; 2008 Mar; 23(3):693-8. PubMed ID: 18192296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
    Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of Gly972Arg and C825T polymorphisms in Slovak women with polycystic ovary syndrome and their relation to the metabolic syndrome.
    Dravecká I; Lazúrová I; Habalová V
    Gynecol Endocrinol; 2010 May; 26(5):356-60. PubMed ID: 20170352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
    Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
    Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.
    Baldani DP; Skrgatić L; Simunić V; Zlopasa G; Canić T; Trgovcić I
    Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
    Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
    Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS.
    Chen MJ; Yang WS; Yang JH; Hsiao CK; Yang YS; Ho HN
    Hum Reprod; 2006 Sep; 21(9):2266-71. PubMed ID: 16757555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early metabolic derangements in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Maliqueo M; Codner E; Echiburú B; Crisosto N; Pérez V; Pérez-Bravo F; Cassorla F
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4637-42. PubMed ID: 17848407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.
    Boyle JA; Cunningham J; Norman RJ; Dunbar T; O'Dea K
    Intern Med J; 2015 Dec; 45(12):1247-54. PubMed ID: 26387977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.
    Coviello AD; Legro RS; Dunaif A
    J Clin Endocrinol Metab; 2006 Feb; 91(2):492-7. PubMed ID: 16249280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
    Shroff R; Syrop CH; Davis W; Van Voorhis BJ; Dokras A
    Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.